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ONE HEALTH
Endemic zoonoses in the tropics:
a public health problem hiding in 
plain sight
The resurgence of interest in One 
health over the past decade has 
been fuelled by global concerns 
relating to zoonotic diseases with 
pandemic potential, such as highly 
pathogenic avian influenza A h5N1, 
severe acute respiratory syndrome 
coronavirus (SARS-CoV) and ebola. 
early advocates of One health such 
as Calvin Schwabe became aware 
of the importance of integrating 
veterinary and medical approaches 
through work on endemic diseases 
of people and livestock (Schwabe 
1984). 
Today, endemic zoonoses 
continue to inflict an enormous 
disease burden, particularly across 
tropical regions. endemic zoonoses 
affect human health and wellbeing 
directly as common causes of human 
disease, and indirectly through impacts on 
livelihoods and food security as a result of 
livestock production losses. Despite these 
multiple impacts, endemic zoonoses are still 
rarely recognised and are poorly understood. 
Their widespread mismanagement 
contributes to a vicious cycle of ill-health 
and poverty. here, we review the factors that 
contribute to the ‘invisibility’ of endemic 
species), plague (Yersinia pestis), Rift 
Valley fever and Chikungunya 
(both caused by arboviruses), and 
many others, pose considerable 
challenges for clinicians in both 
human and animal health. They 
frequently present with general 
symptoms that are shared with a 
wide range of infectious diseases 
common in the tropics, and are hard 
to identify or differentiate clinically. 
As a consequence, the true burden 
of endemic zoonoses is largely 
underappreciated and awareness 
among clinicians and policymakers 
remains limited. 
In humans, non-specific 
symptoms such as fever, headache, 
fatigue, and joint or muscle aches 
are commonly associated with 
many endemic zoonoses. These symptoms 
also occur with common non-zoonotic 
diseases, such as malaria and typhoid fever, 
which are likely to be considered more 
readily by clinicians (Crump 2012, 2014). 
Considerable social influences, such as 
training context, the influence of peers, 
and pressure to meet patient expectations, 
can also contribute to the overdiagnosis of 
diseases such as malaria, and thus to the 
relative underdiagnosis of other diseases 
including many zoonoses (Chandler and 
others 2008). even well-recognised zoonotic 
diseases with distinctive clinical signs may 
be misdiagnosed as malaria. For example, 
in a study of childhood encephalitis in a 
malaria-endemic region of Malawi, rabies 
was confirmed as the cause of 10.5 per cent 
of fatal cases of encephalitis. Several of these 
cases were originally attributed to cerebral 
malaria, with clinical manifestations 
indistinguishable from those of cerebral 
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‘Even well-recognised zoonotic 
diseases with distinctive clinical signs 
may be misdiagnosed as malaria’
zoonoses as a global health problem with 
a focus on Africa, and highlight the crucial 
importance and value of One health 
approaches to effectively tackle these 
diseases. 
Non-specific disease syndromes
endemic zoonoses such as brucellosis 
(Brucella species), Q fever (Coxiella burnetii), 
leptospirosis (Leptospira species), rickettsioses 
(Rickettsia species), bartonellosis (Bartonella 
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malaria, but with subsequent histological 
examination showing no evidence of 
sequestration of parasitised erythrocytes 
in cerebral tissues (a hallmark of cerebral 
malaria) (Mallewa and others 2007). 
More specific symptoms may occur 
with some zoonotic diseases, but these lack 
sensitivity or specificity, so cannot be relied 
upon for a clinical diagnosis. For example, 
hepatomegaly and splenomegaly are often 
reported in cases of human brucellosis 
(World health Organization [WhO] and 
others 2006), but vary in the degree to which 
they are observed within and between 
different populations (Bouley and others 
2012, Dean and others 2012a). In northern 
Tanzania, 18.8 per cent of patients with a 
confirmed diagnosis of acute brucellosis also 
had hepato- or splenomegaly on physical 
examination (Bouley and others 2012). 
Similarly, pneumonia is often considered 
one of the main presentations of Q fever in 
humans; however, in a hospital-based study 
in Taiwan, only 13.5 per cent of confirmed 
cases of acute Q fever presented with 
respiratory symptoms (Lai and others 2014).
epilepsy is one of the most common 
neurological conditions in Africa, estimated 
to affect 4.4 million people and having 
significant physical, economic and social 
consequences (Paul and others 2012). 
Neurocysticercosis, caused by the tapeworm 
Taenia solium, is increasingly recognised as 
a major cause of epilepsy, with a meta-
analysis of studies in Latin America, 
India and sub-Saharan Africa identifying 
neurocysticercosis as the cause of 30 per 
the number of differential diagnoses for 
common disease syndromes can be large 
and capacity to conduct reliable diagnostic 
tests for the possible aetiologies is often 
limited. The lack of neurological imaging 
facilities, such as computerised tomographic 
scans, contributes substantially to a lack of 
information on the causes of neurological 
syndromes. 
There are few laboratories in Africa 
with the capacity to perform direct pathogen 
isolation or detection in acutely ill patients 
by blood culture or by molecular diagnostic 
assays such as nucleic acid amplification 
to the diagnosis of animal infection. For 
some zoonoses, for example Escherichia coli 
O157 in livestock and T brucei rhodesiense in 
wildlife, zoonotic infections often cause no 
apparent clinical signs in the animal host. 
even where clinical signs of disease are seen 
(for example, with Q fever, brucellosis and 
leptospirosis), the level of disease recognition 
and reporting is likely to be several fold 
lower in livestock than in humans, ensuring 
that animal healthcare providers often 
have even less observational data to inform 
diagnoses than their medical colleagues. 
Abortions are often one of the most 
readily recognisable signs of infectious 
illness in livestock and can have severe 
impacts on individual animal and herd 
productivity. Data concerning the incidence 
of livestock abortions and other productivity 
measures are frequently lacking in livestock-
dependent settings. however, a study 
in northern Tanzania reported abortion 
events in 19 per cent of cattle herds, and 
33 per cent of sheep/goat flocks, with 12.9 
per cent of female domestic ruminants 
having a history of at least one abortion 
(Shirima 2005). Infection with several 
of the priority zoonoses of the World 
Organisation for Animal health (OIe), 
including Brucella, Leptospira and Streptococcus 
species, Campylobacter, Chlamydia, Ehrlichia, 
Anaplasma, Borrelia burgdorferi and C burnetii 
can cause abortion in livestock species 
and other animals. The fact that so many 
zoonoses affecting people in the tropics 
also cause abortion in livestock suggests 
that there is likely to be great value in One 
health approaches that link aetiological and 
epidemiological studies of livestock abortion 
with research on common human health 
syndromes. 
Diagnostic capacity
In many developing countries, a lack of 
laboratory diagnostic capacity adds to the 
challenges that clinicians face in establishing 
a diagnosis for zoonotic causes of human 
illness. even with thorough history taking 
and careful evaluation of clinical signs, 
A doctor hands over 
malaria medication at 
a hospital in Senegal. 
Studies have shown 
that, in tropical regions, 
zoonotic diseases 
in people are often 
misdiagnosed as malaria 
as they have similar 
symptoms
cent cases of epilepsy (Ndimubanzi and 
others 2010). Other endemic parasitic 
zoonoses that contribute to neurological 
syndromes in the tropics include Trypanosoma 
brucei rhodesiense, the zoonotic cause of 
human African sleeping sickness; and 
toxoplasmosis, which is the leading cause 
of central nervous system (CNS) disease 
in hIV-infected patients. A wide range 
of zoonotic parasitic diseases, including 
echinococcosis and trichinosis, as well as 
non-parasitic zoonoses, such as leptospirosis 
and borreliosis, also have the potential 
to cause a range of CNS signs, and may 
contribute to the burden of neurological 
disease in endemic areas.
The challenge of non-specific 
presentation of many zoonoses also applies 
‘Even where clinical signs of disease 
are seen . . . the level of disease 
recognition and reporting is likely 
to be several fold lower in livestock 
than humans, ensuring that animal 
healthcare providers often have 
even less observational data to 
inform diagnoses than their medical 
colleagues’
‘The fact that so many zoonoses 
affecting people in the tropics also 
cause abortion in livestock suggests 
that there is likely to be great value 
in One Health approaches that link 
aetiological and epidemiological 
studies of livestock abortion with 
research on common human health 
syndromes’
by PCR (Petti and others 2006). Culture 
and isolation of many zoonotic pathogens 
can be hazardous and laboratory-acquired 
infections pose a real risk for laboratory 
personnel. Attempts to culture hazard 
Group 3 pathogens such as Brucella, Coxiella 
and Mycobacterium species should only 
be made in diagnostic laboratories with 
appropriate containment facilities, which 
are few and far between in low-income 
countries. 
Serological diagnostic tests are more 
widely available and safer to conduct; 
however, many rely on demonstrating rising 
antibody titres for definitive diagnoses. 
As this is measured in paired acute and 
convalescent samples collected over a 
two- to six-week period, diagnoses based 
on seroconversion are only made weeks 
after initial patient presentation and cannot 
inform the clinical management of acutely 
ill patients. 
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high levels of ‘background’ exposure 
in some populations can complicate the 
interpretation of serological data for endemic 
pathogens (Levett 2001). Furthermore, many 
existing serological tests are hampered by 
inadequate test performance, including poor 
specificity, reproducibility and reliability. 
For example, a study of brucellosis in Kenya 
demonstrated a poor agreement between 
serological test results from four rural health 
facilities when compared with results from 
the central veterinary laboratory (Maichomo 
and others 1998). 
Diagnosis of zoonotic infections in 
animals is also difficult in resource-limited 
settings. historically, epidemiological 
studies have relied mainly on serological 
surveys that demonstrate the extent of 
exposure in different animal populations. 
however, data gathered through serosurveys 
cannot inform understanding of pathogen 
shedding dynamics, which is critical for 
understanding zoonotic transmission risks. 
In many cases, serological assays also lack 
the specificity to differentiate between 
pathogen species or strain types. Serological 
tests cannot distinguish between infections 
with Brucella abortus or Brucella melitensis, 
for example, and there is considerable 
cross-reactivity between different Leptospira 
serovars. This lack of specificity has 
important implications for the identification 
of sources of infection and for the 
development of vaccination strategies. The 
use of culture and molecular methods for 
pathogen detection in animals has also 
been limited by many of the infrastructure 
and logistical restrictions that affect human 
disease diagnostics. In combination with a 
lack of research prioritisation, these factors 
play an important role in perpetuating 
low levels of knowledge and awareness of 
zoonotic pathogens circulating in livestock, 
domestic animals and wildlife populations. 
Delays in case presentation
Delayed healthcare-seeking behaviour of 
patients, coupled with the chronic nature 
of many zoonotic conditions, can further 
compound challenges in acute disease 
diagnosis as detection of pathogens can 
be difficult at later stages of infection. A 
study of healthcare-seeking behaviour 
among patients diagnosed with brucellosis 
in northern Tanzania revealed that just 22 
per cent of cases sought care at a hospital 
within the first month after the onset 
of their symptoms (Kunda and others 
2007). The sensitivity of blood culture for 
diagnosis of brucellosis is low even in the 
acute phase of disease and falls even further 
in the diagnosis of longstanding disease 
endemic zoonoses remain widely neglected 
in many low-income settings because their 
impact is borne largely by impoverished and 
marginalised communities (Molyneux and 
others 2011). They disproportionately affect 
people who are not only at high risk of 
pathogen exposure but also have little access 
to adequate primary healthcare (ILRI 2012). 
even when reliable point-of-care 
diagnostic tests become more widely 
available for clinical management of 
common illnesses, health facilities serving 
these communities are those least likely 
to be able to establish diagnostic capacity. 
Inequalities in access to healthcare facilities 
are also likely to be a major contributing 
factor to underdiagnosis and under-reporting 
of zoonotic disease in Africa and other 
tropical regions (Molyneux and others 
2011, ILRI 2012). Consequently, zoonotic 
diseases of impoverished communities 
continue to be overlooked in global disease 
control priorities, and the cycle of neglect is 
perpetuated by the lack of reliable data on 
incidence and impact.
Assessing the impacts
There are many steps in quantifying 
the overall impact of a given disease. 
Identification of individual cases is the first 
step in the process. Measures of disease 
incidence alone are only a first step towards 
prioritisation of investment in disease 
control to improve overall public health, as 
they do not encompass any information 
about the impacts of a disease on an 
individual or population. 
In human health, a variety of measures 
have been developed to quantify the 
multiple impacts of disease, such as quality 
of life and economic impacts of disease. 
The Global Burden of Disease study of the 
WhO and many other organisations and 
studies use disability-adjusted-life-years 
(DALYs) to measure and compare the burden 
of a wide range of different diseases and 
enable rational prioritisation of investment 
in healthcare. DALYs combine years of life 
lost to premature mortality and years of life 
lost due to time lived in states of less than 
full health to measure the impact of illness 
on an individual (WhO 2015). however, 
DALYs do not incorporate any measure of 
other kinds of disease impact, such as the 
economic costs of illness for the individual 
or society (Grace and others 2012). Crucially 
for the evaluation of the impact of zoonoses, 
DALYs do not include any measure of the 
impact of zoonoses upon animal health 
either directly or through the costs of lost 
animal productivity. These may include, 
for example, the impact of reduced milk 
production on child health and nutrition; the 
economic impacts of reduced reproductive 
success or abortion in commercially 
valuable livestock species, and the secondary 
consequences of the loss of draught power 
for subsistence farmers. 
Goats and children from 
a household in Tanzania 
in which both people 
and livestock had been 
affected by brucellosis
(WhO and others 2006). Similarly, in 
patients with leptospirosis, leptospires can 
only be detected in the blood of an infected 
person within the first week of clinical 
illness. Selection of appropriate diagnostic 
specimens is dependent on timing and 
requires careful history taking with regards 
to the timing of onset of clinical symptoms 
(haake and Levett 2015). Isolation rates 
from blood culture can be very low even 
if patients are sampled during the acute 
febrile stages of illness (Levett 2001). In the 
absence of an acute phase sample, serological 
diagnosis is complex and often inconclusive 
for most endemic zoonoses. 
Neglected diseases in neglected 
populations
Many zoonotic diseases that are overlooked 
in endemic settings are not universally 
neglected. Brucellosis, for example, has 
been well-studied and eradicated in several 
countries with highly developed commercial 
livestock sectors (Dean and others 2012b). 
‘Zoonotic diseases of impoverished 
communities continue to be 
overlooked in global disease control 
priorities, and the cycle of neglect is 
perpetuated by the lack of reliable 
data on incidence and impact’
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While frameworks exist for economic 
evaluation of zoonoses (Narrod and 
others 2012), there are currently no 
standardised metrics equivalent to the 
DALY that integrate the multiple impacts 
of zoonoses on human and animal health. 
Consequently, the burden of these diseases 
is, at best, only partially quantified and 
their significance often underestimated, 
particularly when viewed alongside diseases 
that affect only human health (Grace and 
others 2012). 
One Health approaches
Given the considerable challenges in the 
diagnosis and management of endemic 
zoonotic diseases in Africa, interest has 
been growing in the benefits of adopting 
a more integrated One health approach 
that involves both human and animal 
health sectors. The sections below outline 
the rationale, application and added value 
of these approaches. We also provide 
illustrations of the progress that has been 
made through adoption of these approaches 
and highlight some priorities for future 
work. 
Several comprehensive aetiological 
studies using gold-standard diagnostics have 
now been conducted in Africa and Asia to 
better define the contribution of a broad 
spectrum of infectious diseases to common 
clinical syndromes such as febrile or 
neurological illness. These studies invariably 
reveal that zoonotic infections cause 
substantial proportions of human illness, 
and confirm high levels of misdiagnosis 
of zoonotic illnesses (Suttinont and others 
2006, Gasem and others 2009, Manock 
and others 2009, Kendall and others 2010, 
Crump and others 2013).
For example, in a prospective cohort 
study involving 870 febrile patients in 
northern Tanzania (Crump and others 
2013), malaria was the clinical diagnosis 
in the majority of cases (60.7 per cent), but 
was the actual cause of fever in very few 
(1.6 per cent). In fact, bacterial zoonoses, 
which were not initially considered by 
clinicians in any cases, were confirmed 
through reference laboratory diagnostic 
testing of paired acute and convalescent 
serum samples as a cause of disease in 26.2 
per cent of all febrile admissions. These 
zoonoses included leptospirosis (8.8 per cent 
of all febrile admissions), spotted fever group 
rickettsioses (8.0 per cent), Q fever (5.0 per 
cent), brucellosis (3.5 per cent) and typhus 
group rickettsioses (0.4 per cent). In two sites 
(one rural, one urban) in southern Tanzania, 
leptospirosis, Q fever, toxoplasmosis and 
rickettsial infections were also identified 
as causes of febrile illness in people 
(D’Acremont and others 2014). 
Aetiological studies such as these 
help to raise awareness of the presence 
and importance of many zoonoses. 
Unfortunately, however, these studies 
typically employ diagnostic approaches 
that provide retrospective diagnoses only or 
tests that are not routinely available in many 
settings and cannot necessarily be extended 
to provide diagnostic solutions for primary 
healthcare providers.
Intersectoral communication
Many of the same endemic zoonotic 
pathogens occur widely in both human and 
animal populations across Africa and other 
tropical regions, and there is substantial 
information available on distribution 
patterns, largely through prevalence surveys. 
This is demonstrated in systematic literature 
reviews of brucellosis (Dean and others 
2012b, Rubach and others 2013), Q fever 
(Vanderburg and others 2014), leptospirosis 
factors for animal and human infections in 
different environments. This understanding 
will be important for establishing evidence-
based public health policy and in developing 
clinical algorithms for disease risk to guide 
clinicians in diagnostic test selection and 
patient management. For example, in east 
Africa the prevalence of brucellosis appears 
to be substantially higher in both human 
and animal populations living in pastoral 
communities than in smallholder farming 
areas (McDermott and Arimi 2002). 
Brucellosis should therefore be considered a 
more likely cause of febrile illness in patients 
living in high-risk communities. exposure 
to T solium infection is associated with 
community-level pig ownership and lower 
levels of sanitation. Thus, neurocysticercosis 
should be considered as a differential 
diagnosis of epilepsy where pig-keeping is 
practised in the patient’s home community 
(Assana and others 2013). Ongoing 
communication is required to enable the 
translation of findings in one sector into 
practice in the other. 
For many endemic zoonoses, we still 
have a poor understanding of specific 
risk factors for both human and animal 
infection, and this lack of knowledge 
is likely to contribute substantially to 
under-recognition of clinical impacts of 
disease in animal and human populations. 
For example, exposure to T gondii occurs 
throughout Africa, with some indication 
of decreasing prevalence from north to 
south, and from west to east (hammond-
Aryee and others 2014). however, the 
specific risk factors underlying these 
geographic trends remain unknown. Q 
fever is similarly pervasive, and although 
risk factors for animal and human infection 
have been identified in some settings (for 
example, associations with camels in Chad 
[Schelling and others 2003], and owner’s 
ethnic group in Cameroon [Mazeri and 
others 2013]), much remains unknown 
about epidemiological risk factors in 
Africa. Leptospira infections have also 
Blood sampling of 
Tanzanian livestock 
workers at risk 
of infection with 
brucellosis
‘In a prospective cohort study 
involving 870 febrile patients in 
northern Tanzania, malaria was the 
clinical diagnosis in the majority of 
cases (60.7 per cent), but was the 
actual cause of fever in very few 
(1.6 per cent)’
(de Vries and others 2014, K. J. Allan, 
personal communication), cysticercosis (Zoli 
and others 2003, Winkler 2012, Assana 
and others 2013), Toxoplasma gondii infection 
(hammond-Aryee and others 2014) and 
zoonoses overall (ILRI 2012). however, there 
is still a need for improved communication 
of information across sectors to inform 
diagnosis, clinical management and disease 
control strategies.
Many endemic zoonoses should be 
considered in the list of possible aetiologies 
for relevant human disease syndromes in 
most, if not all, parts of Africa. however, 
there is considerable local variation in 
prevalence and incidence in both human 
and animal populations globally, which 
suggests a need for greater understanding of 
local patterns of persistence and specific risk 
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been detected in a wide range of animal 
hosts in Africa, including livestock and 
many wildlife species. however, marked 
variation in prevalence and strain type 
of infecting serovars exist and little is 
known about the factors that influence 
disease transmission in a wide range of 
agroecological settings. Additional linked 
analyses of these neglected zoonoses in 
human and animal populations are needed 
to: (i) synthesise the data that are currently 
available; and (ii) reveal key features of the 
epidemiology of these pathogens that can 
only be appreciated when the true multihost 
nature of that epidemiology is explicitly 
considered.
Molecular epidemiology and new 
surveillance approaches
Increasingly, the rapid advancement of PCR-
based nucleic acid detection methods and 
high throughput sequence analysis for strain 
identification is providing new opportunities 
to understand the multihost epidemiology 
of endemic zoonoses. 
high-resolution genetic typing data 
allow the characterisation and comparison 
of pathogens present in humans and animal 
hosts, enabling identification of likely 
infection sources and transmission routes 
to people. To effectively use the disease 
control opportunities provided by these 
new diagnostic techniques (for example, 
identification of key intervention points), 
there is a need to develop novel surveillance 
approaches that enable targeted collection of 
diagnostic material suitable for application 
of these techniques. In most cases this will 
require responsive sampling of clinical cases, 
in which detection of the infecting pathogen 
is feasible, rather than cross-sectional sero-
surveillance. There is great scope to develop 
syndromic approaches to disease detection 
and diagnostics in animal populations. 
For example, livestock abortions are often 
noticed by the farmer, and thus may provide 
a memorable event around which to base a 
livestock surveillance system for many key 
zoonotic pathogens. 
Laboratory testing of diagnostic 
material from abortion events, including 
pathogen detection and molecular 
characterisation, has great potential 
for enhancing our understanding of 
the epidemiology of many infections 
in livestock populations. In the case 
of brucellosis, despite numerous 
seroprevalence surveys, very little is still 
known about the relative contribution 
of different Brucella species to the disease 
burden in both animal and human 
populations in east Africa. Being able 
to distinguish the role and risk factors 
for B abortus and B melitensis in different 
host species is clearly a fundamental and 
urgent requirement before effective control 
measures including animal vaccination can 
begin. 
Disease control at source vs  
fire-fighting
Perhaps the greatest added value to be 
gained through the adoption of One health 
approaches is the opportunity to implement 
control programmes that reduce the multiple 
impacts of zoonoses in both human 
and animal populations. Interventions 
that may control zoonotic infection in 
animal populations or prevent disease 
transmission from animals to people may 
offer more effective and economically viable 
approaches to disease management than 
those focusing on the human population 
alone. This is particularly true where 
zoonotic infections have a detrimental 
effect on household livelihoods through 
the impacts of infection on livestock 
reproductive success and productivity. 
Many effective interventions against 
zoonotic diseases are already available 
for livestock, with the potential to bring 
immediate benefits to both human and 
animal health. For example, effective 
infection as well as those least able to access 
appropriate healthcare when suffering 
from disease, a One health approach offers 
more widespread and equitable benefits 
than relying on medical treatment at health 
facilities alone.
 
Conclusion
The One health paradigm encourages a 
holistic perspective. When considering 
endemic zoonoses, this breadth of 
perspective is essential to appreciate the 
full range of impacts of these diseases that 
are too often overlooked. The non-specific 
clinical presentation of many zoonoses, 
the complexity of diagnostics for these 
diseases and the relative lack of data on their 
clinical burdens all contribute to the under-
recognition of their importance and thus to 
their ongoing neglect. 
There is considerable potential 
for the application of molecular 
diagnostic approaches to greatly improve 
understanding of the distribution and 
fine-scale transmission processes of many 
endemic zoonoses. however, even with 
the widespread availability of cutting-edge 
diagnostic capacities, the diagnosis of many 
zoonoses will remain challenging and it is 
clear that improved front line diagnostic 
capacity alone cannot be the only measure 
taken to effectively tackle the multiple 
impacts of these diseases. 
As well as efforts to build diagnostic 
capacity and improve the management 
of individual cases, there is a need to 
implement preventive and control 
measures that tackle these diseases in 
a much more fundamental way. This 
research should include studies into the 
practical implementation and evaluation 
of disease control programmes that reduce 
transmission in animal populations, control 
zoonotic diseases at their source and thus 
reduce their impacts on human health, 
animal health and livelihoods.
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livestock vaccines are available for the 
control of brucellosis, Q fever, leptospirosis, 
anthrax (Bacillus anthracis) and toxoplasmosis 
(T gondii). however, these have rarely been 
deployed in large-scale control programmes 
in low-resource settings, partly because the 
rationale for livestock vaccination tends 
to be argued only from the perspective of 
the livestock sector and in terms of private 
good to the livestock owner. Conversely, 
approaches to cost-effectiveness analysis 
of health interventions typically consider 
only the human health benefits, which 
represent only one component of societal 
benefits of zoonoses control. Incorporating 
public health benefits (for example, DALYs 
avoided), livestock production gains and 
livelihood benefits into these evaluations 
can substantially improve cost-effectiveness 
measures, and have provided a convincing 
rationale for advocating livestock 
vaccination against brucellosis in Mongolia 
(Roth and others 2003) and livestock 
interventions for control of trypanosomiasis 
(Shaw and others 2006). 
effective control of disease in animal 
host populations also has the potential to 
address issues of health equity through 
prevention of disease transmission to the 
whole community. By offering protection 
to those who are most at risk from 
‘Interventions that may control 
zoonotic infection in animal 
populations or prevent disease 
transmission from animals to people 
may offer more effective and 
economically viable approaches to 
disease management than those 
focusing on the human population 
alone’
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